Table 2.
Varianta | Change in susceptibility (EC50 fold change) tob: |
||||||
---|---|---|---|---|---|---|---|
BI 201335 | MK-7009 | TMC435 | ITMN-191 | Boceprevir | Telaprevir | IFN-α | |
WT GT 1a H77 | |||||||
D168V | 620 ± 180 | 1,000 ± 460 | 780 ± 170 | 86 ± 16 | ND | ND | 0.8 ± 0.2 |
R155K | 360 ± 90 | 260 ± 22 | 43 ± 8 | 140 ± 41 | 4.2 ± 0.7 | 2.9 ± 1.3 | 0.8 ± 0.2 |
WT GT 1b CON-1 | |||||||
A156V | 150 ± 10 | ND | 160 ± 9 | 5.7 ± 2.1 | 5.2 ± 0.4 | >74d | 1.9 ± 0.2 |
R155Q | 60 ± 9 | 84 ± 62 | 1.6c | 19 ± 2.8 | 1.4c | 2.5c | 0.9 ± 0.2 |
R155K | 350 ± 14 | 220e | 30c | 447c | 4.0f | 10f | 0.6 ± 0.2 |
A156T | 270 ± 98 | 76 ± 32 | 44c | 4 ± 1.2 | 85f | >30 | 1.2 ± 0.4 |
D168G | 80 ± 30 | ND | 4.4c | 8.1c | 0.4c | ND | 0.8 ± 0.1 |
D168A | 690 ± 332 | 220 ± 12 | 594c | 30 ± 3.2 | 0.7c | 0.4c | 1.5 ± 0.5 |
D168V | 970 ± 256 | 560 ± 120 | 1,140 ± 570 | 50 ± 10 | 0.7 ± 0.1 | 0.5 ± 0.1 | 0.9 ± 0.4 |
V36M | 2.1 ± 0.5 | 2.0 ± 0.7 | 2.7 ± 0.5 | 2.1 ± 0.4 | 2.0 ± 0.4 | 7.0d | 0.8 ± 0.2 |
T54A | 0.9 ± 0.2 | 0.6 ± 0.3 | 0.9 | 0.5 ± 0.2 | 6.0f | 6.3d | 0.9 ± 0.2 |
T54S | 3.5 ± 0.7 | ND | 1.2c | 1.2 ± 0.5 | 5.0 ± 0.07 | 3.0 | 0.9 ± 0.2 |
Q80K | 2.2 ± 0.1 | 2.9 ± 0.2 | 14 ± 1.3 | 2.3 ± 0.3 | 1.0 ± 0.1 | 0.9 ± 0.04 | 1.0 ± 0.1 |
Q80L | 1.2 ± 0.2 | 1.5 ± 0.1 | 1.9 ± 0.2 | 1.3 ± 0.2 | 1.0 ± 0.06 | 1.0 ± 0.04 | 1.0 ± 0.1 |
Q80N | 0.6 ± 0.1 | 0.8 ± 0.2 | 0.7 ± 0.04 | 0.7 ± 0.2 | ND | 0.5 ± 0.1 | 0.8 ± 0.3 |
Q80R | 2.6 ± 0.5 | 2.6 ± 0.3 | 15 ± 0.7 | 3.1 ± 0.5 | 1.0 ± 0.2 | 0.9 ± 0.04 | 0.9 ± 0.2 |
WT, wild type.
EC50 values were determined after 72 h of incubation with serial dilution of the indicated inhibitor and quantified by real-time reverse transcription-PCR (RT-PCR) for R155Q, A156T, D168A, and D168G variants (10). All other EC50s were obtained from luciferase reporter replicons in 72-h assays. Fold change was calculated as follows: EC50 for the variant/EC50 for the WT. For each condition, the fold change represents the mean ± standard deviation (SD), which was calculated from at least 3 independent experiments. Replicon variants in boldface type represent those selected in replicon colonies resistant to BI 201335. Values in italic type are from published results. ND, not determined.
Published value obtained from reference 12.
Published value obtained from reference 13.
Published value obtained from reference 25.